F. Blengio

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

V. Vitale, R. Corvò, M. Benasso, 1996, Journal of the National Cancer Institute.

Concomitant administration of two standard regimens of chemotherapy and radiotherapy in advanced squamous carcinoma of the head and neck: a feasibility study.

G. Sanguineti, R. Corvò, M. Benasso, 1995, Anticancer Research.

Chemotherapy in head and neck cancer.

M. Benasso, M. Merlano, M. Cavallari, 1994, European journal of cancer. Part B, Oral oncology.

Concomitant alpha-interferon and chemotherapy in advanced squamous cell carcinoma of the head and neck.

M. Benasso, R. Rosso, M. Merlano, 1993 .

Concomitant Alpha‐Interferon and Chemotherapy in Advanced Squamous Cell Carcinoma of the Head and Neck

R. Rosso, M. Merlano, S. Toma, 1993, American Journal of Clinical Oncology.

Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neck.

F. Cognetti, M. Merlano, F. Scasso, 1994, European journal of cancer.

5-Fluorouracil dose intensification and granulocyte-macrophage colony-stimulating factor in cisplatin-based chemotherapy for relapsed squamous cell carcinoma of the head and neck: a phase II study.

I. Ricci, M. Benasso, M. Merlano, 1998, American journal of clinical oncology.

Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients

L. Mainardi, T. Poli, L. Licitra, 2021, Acta oncologica.